Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Open in API
Filings indexed 288 across all filing types
Latest filing 2022-09-02 Major Shareholding Noti…
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is a standard regulatory disclosure for major shareholders (10% or more) or insiders to report changes in their shareholdings. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ) as it details the change in ownership percentage of a major shareholder (Kolon Life Science) in the issuer (Kolon TissueGene).
2022-09-02 Korean
기타시장안내(개선기간 종료에 따른 상장폐지여부 결정 안내)
Delisting Announcement Classification · 100% confidence The document is a short regulatory announcement from the Korea Exchange regarding the status of Kolon TissueGene's listing, specifically concerning the end of an improvement period and the subsequent process for determining potential delisting. It does not constitute a formal delisting notice itself, but rather an update on the regulatory process. Given the nature of the announcement regarding exchange listing status, it fits best under the RNS (Regulatory Filings) category as a miscellaneous regulatory update.
2022-08-31 Korean
주요사항보고서(자본으로인정되는채무증권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korea Exchange regarding the issuance of debt securities (convertible bonds) that qualify as capital. It details the terms of the issuance, including interest rates, put/call options, and the use of proceeds for clinical trial operations. This falls under the category of capital and financing updates.
2022-08-31 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It details the decision to issue convertible bonds (전환사채권 발행결정), including terms, interest rates, conversion prices, and the use of proceeds. This falls under the category of capital structure changes and financing activities.
2022-08-31 Korean
[기재정정]투자판단관련주요경영사항(기술수출 계약 체결(당사의 라이센시인 코오롱생명과학㈜ 주요경영사항))
M&A Activity Classification · 100% confidence The document is a regulatory filing from Kolon TissueGene regarding a 'Correction Report' (정정신고) for a previously disclosed technology export contract. It details changes to the counterparty of a licensing agreement (from Juniper Biologics to Juniper Therapeutix) and provides updated terms of the contract. As this is a formal regulatory announcement regarding material business developments and contract amendments, it falls under the category of general regulatory filings.
2022-08-29 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by Kolon TissueGene. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2022-08-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.